Globus Medical GMED
NYSE GMED
$74.90 -0.82 (-1.08%)
At close: Sep 30, 2026 · 4:00 PM EDT

Globus Medical (GMED) Convertible Debt (2023)

Updated

Globus Medical (GMED) posted Convertible Debt of $417.4 million for Q4 2023, up 1.9% from the prior quarter.

Analysis

Globus Medical (GMED) Convertible Debt (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Globus Medical 10.06 Bn 7.88 Bn 548.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 417.40 Mn
Sep 30, 2023 409.72 Mn
API Access

Globus Medical Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=GMED&period=max&api_key=YOUR_API_KEY